Simulations Plus

Simulations Plus Current Assets

The Current Assets of Simulations Plus (SLP) as of Sep 27, 2026 is 51.55 M USD. In the previous year, Current Assets was 51.14 M USD — a change of 0.80% (higher).

Current Assets

51.55 MUSD

YoY

0.80%

Last updated:

Current Assets of Simulations Plus is 2026 51.55 M USD. Current Assets of Simulations Plus was 2025 51.14 M USD. It decreases by 0.80% higher compared to the previous year.

The Simulations Plus Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
18.14 M USD
Jan 1, 2019
21.97 M USD
Jan 1, 2020
129.08 M USD
Jan 1, 2021
139.26 M USD
Jan 1, 2022
146.80 M USD
Jan 1, 2023
130.37 M USD
Jan 1, 2024
51.14 M USD
Jan 1, 2025
51.55 M USD
The Simulations Plus Current Assets history
YEARCurrent AssetsYoY
51.55 MUSD+0.80%
51.14 MUSD-60.77%
130.37 MUSD-11.19%
146.80 MUSD+5.41%
139.26 MUSD+7.89%
129.08 MUSD+487.51%
21.97 MUSD+21.14%
18.14 MUSD+56.34%
11.60 MUSD-9.23%
12.78 MUSD+16.67%
10.95 MUSD-10.42%
12.23 MUSD-7.65%
13.24 MUSD-9.91%
14.70 MUSD+12.56%
13.06 MUSD+7.13%
12.19 MUSD+19.54%
10.20 MUSD+15.28%
8.85 MUSD+23.15%
7.18 MUSD+93.48%
3.71 MUSD+13.31%
3.28 MUSD+5.87%
3.09 MUSD+61.38%
1.92 MUSD+62.34%
1.18 MUSD+57.71%
749,010.00USD+7.64%
695,852.00USD-17.70%
845,497.00USD-10.70%
946,829.00USD-65.94%
2.78 MUSD+363.26%
600,000.00USD+20.00%
500,000.00USD—
Access this data via the Eulerpool API

Simulations Plus Stock analysis

What does Simulations Plus do? Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health. The translation of the text is: "Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health." Simulations Plus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Simulations Plus stock

Current Assets of Simulations Plus is 51.55 M USD in 2026.

Current Assets of Simulations Plus changed from 51.14 M USD to 51.55 M USD, representing a 0.80% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Simulations Plus since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Simulations Plus historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Simulations Plus

All Key Metrics — Simulations Plus